Preventive vaccines against bioterrorism: evaluation of efficacy and safety

被引:4
|
作者
Horne, AD
Clifford, J
Goldenthal, KL
Kleppinger, C
Lachenbruch, PA
机构
[1] US FDA, Div Biostat, Off Biostat & Epidemiol, CBER, Rockville, MD 20852 USA
[2] US FDA, Div Vaccines & Related Prod Applicat, Off Vaccine Res & Review, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA
[3] NIDA, Ctr Clin Trials Network, NIH, Bethesda, MD 20892 USA
关键词
immunogenicity; non-inferiority; Animal Rule;
D O I
10.1016/j.vaccine.2004.04.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This paper discusses the US Food and Drug Administration's approach to evaluation of vaccines in general, and vaccines against diseases of bioterrorism in particular. We summarize the scientific bases for development and approval of vaccines and then discuss specific issues regarding vaccines against disease organisms that could potentially be used as weapons of bioterrorism. Published by Elsevier Ltd.
引用
收藏
页码:84 / 90
页数:7
相关论文
共 50 条
  • [1] Vaccines in civilian defense against bioterrorism
    Russell, PK
    EMERGING INFECTIOUS DISEASES, 1999, 5 (04) : 531 - 533
  • [2] Evaluation of efficacy and safety of Aujeszky's disease vaccines
    Lipowski, A
    POLISH JOURNAL OF VETERINARY SCIENCES, 2006, 9 (01): : 75 - 79
  • [3] Safety and Efficacy of the Common Vaccines against COVID-19
    Liu, Ying
    Ye, Qing
    VACCINES, 2022, 10 (04)
  • [4] Safety and efficacy of vaccines
    Bartlett, Brenda L.
    Tyring, Stephen K.
    DERMATOLOGIC THERAPY, 2009, 22 (02) : 97 - 103
  • [5] EFFICACY AND SAFETY OF VACCINES
    VANOIRSCHOT, JT
    VETERINARY QUARTERLY, 1994, 16 : S7 - S8
  • [6] Safety and efficacy studies on trivalent inactivated vaccines against infectious coryza
    Gong, Yumei
    Zhang, Peijun
    Wang, Hongjun
    Zhu, Wenge
    Sun, Huiling
    He, Yunxia
    Shao, Qinghong
    Blackall, P. J.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2014, 158 (1-2) : 3 - 7
  • [7] In vitro model for the evaluation of the efficacy of putative vaccines against atherosclerosis
    Mundkur, L. A.
    Kumar, K.
    Varma, M.
    Lu, X.
    Kakkar, V. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 599 - 599
  • [8] EVALUATION OF THE EFFICACY OF REPEAT VACCINATIONS AGAINST INFLUENZA BY INACTIVATED VACCINES
    AVRATINSKY, IM
    STEPANKOVSKAYA, LD
    KATUNTSEVSKAYA, GP
    KIRILIUK, ZI
    KALITSEV, VA
    YAMPOLSKY, MP
    BURDENIUK, EI
    VRACHEBNOE DELO, 1992, (03): : 79 - 81
  • [9] Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves
    Petrini, S.
    Ramadori, G.
    Corradi, A.
    Borghetti, P.
    Lombardi, G.
    Villa, R.
    Bottarelli, E.
    Guercio, A.
    Amici, A.
    Ferrari, M.
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2011, 34 (01) : 3 - 10
  • [10] The development of antimicrobials and vaccines against bacterial bioterrorism agents - Where are we?
    Gilligan, PH
    DRUG DISCOVERY TODAY, 2004, 9 (05) : 205 - 206